MX9706049A - Adresinas vasculares mucosas y sus usos. - Google Patents
Adresinas vasculares mucosas y sus usos.Info
- Publication number
- MX9706049A MX9706049A MX9706049A MX9706049A MX9706049A MX 9706049 A MX9706049 A MX 9706049A MX 9706049 A MX9706049 A MX 9706049A MX 9706049 A MX9706049 A MX 9706049A MX 9706049 A MX9706049 A MX 9706049A
- Authority
- MX
- Mexico
- Prior art keywords
- madcam
- primate
- recombinant
- proteins
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- External Artificial Organs (AREA)
Abstract
La presente invencion se refiere a ácidos nucleicos recombinantes y/o alejados, que codifican MadCAMs primates, y a proteínas de polipéptidos que aquí se refieren como MadCAMs primates recombinantes y/o aisladas. Además, la invencion se refiere a constructores ácidos nucleicos recombinantes, que comprenden un ácido nucleico que codifica una MadCAM primate de la presente invencion, una parte de la misma o una variante, a células huésped que comprenden dichos constructores, utiles para la produccion de proteínas recombinantes; el uso de ácidos nucleicos y/o proteínas de ensayos para identificar los inhibidores (por ejemplo, antagonistas) de la funcion de MAdCAM primate; y a anticuerpos reactivos con la MadCAM primate, los cuales son utiles en métodos in vitro y aplicaciones terapéuticas o diagnosticas. De igual modo, la invencion se refiere al tratamiento de individuos, particularmente humanos, que sufren de una enfermedad (por ejemplo, la enfermedad inflamatoria del intestino) asociada con el aumento de leucocitos en el aparato gastrointestinal u otros tejidos, por ejemplo, como resultado de la union de leucocitos a las células que expresan la molécula MAdCAM (endotelio asociado con el intestino), que comprenden administrar el individuo una cantidad efectiva de un agente, tal como un anticuerpo, que inhiba la union de los leucocitos a la MAdCAM.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/386,857 US6551593B1 (en) | 1995-02-10 | 1995-02-10 | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
| US08/523,004 US7750137B2 (en) | 1995-09-01 | 1995-09-01 | Mucosal vascular addressins |
| PCT/US1996/002153 WO1996024673A1 (en) | 1995-02-10 | 1996-02-12 | Mucosal vascular addressins and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9706049A true MX9706049A (es) | 1998-02-28 |
Family
ID=27011628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9706049A MX9706049A (es) | 1995-02-10 | 1996-02-12 | Adresinas vasculares mucosas y sus usos. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0808367B1 (es) |
| JP (1) | JP4205162B2 (es) |
| AT (1) | ATE366809T1 (es) |
| AU (1) | AU4986296A (es) |
| CA (1) | CA2212702C (es) |
| DE (1) | DE69637155T2 (es) |
| DK (1) | DK0808367T3 (es) |
| ES (1) | ES2290955T3 (es) |
| MX (1) | MX9706049A (es) |
| NZ (1) | NZ303523A (es) |
| PT (1) | PT808367E (es) |
| WO (1) | WO1996024673A1 (es) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001503271A (ja) * | 1996-11-01 | 2001-03-13 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | ヒト粘膜アドレシン細胞接着分子―１（ＭＡｄＣＡＭ―１）およびそのスプライス変異体 |
| WO1998051345A2 (en) * | 1997-05-09 | 1998-11-19 | The John P. Robarts Research Institute | Method for dislodging infiltrated leukocytes from a tissue |
| EP1078006B1 (en) * | 1998-05-13 | 2009-03-04 | Genentech, Inc. | Diagnosis and treatment of hepatic disorders |
| AU2007201698B2 (en) * | 1998-05-13 | 2011-10-13 | Genentech, Inc. | Diagnosis and treatment of hepatic disorders |
| US7090845B2 (en) | 1998-05-13 | 2006-08-15 | Genentech, Inc. | Diagnosis and treatment of hepatic disorders |
| AUPR524101A0 (en) | 2001-05-25 | 2001-06-21 | Council Of The Queensland Institute Of Medical Research, The | Antigen targeting |
| WO2003047526A2 (en) * | 2001-11-30 | 2003-06-12 | Incyte Genomics, Inc. | Cell adhesion and extracellular matrix proteins |
| WO2004081049A1 (en) * | 2003-03-10 | 2004-09-23 | Auckland Uniservices Limited | Monoclonal antibodies that recognise mucosal addressin cell adhesion molecule-1 (madcam-1), soluble madcam-1 and uses thereof |
| BRPI0409850A (pt) | 2003-05-01 | 2006-05-09 | Scripps Research Inst | antagonistas seletivos de r-caderina e métodos |
| PA8621301A1 (es) | 2004-01-09 | 2006-09-22 | Pfizer | ANTICUERPOS CONTRA MAdCAM |
| CN104710532B (zh) * | 2004-09-03 | 2019-01-18 | 健泰科生物技术公司 | 人源化的抗-β7拮抗剂及其应用 |
| JP2009500390A (ja) | 2005-07-08 | 2009-01-08 | ファイザー・リミテッド | 新規ＭＡｄＣＡＭ抗体 |
| WO2007007152A2 (en) * | 2005-07-11 | 2007-01-18 | Pfizer Limited | Anti-madcam antibodies to treat metastatic cancers and chloroma |
| US20100255508A1 (en) * | 2008-05-16 | 2010-10-07 | Thomas Richard Gelzleichter | Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists |
| PH12018502221B1 (en) | 2011-05-02 | 2023-05-10 | Millennium Pharm Inc | FORMULATION FOR ANTI-a4Ã7 ANTIBODY |
| UA116189C2 (uk) | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
| WO2016086147A1 (en) | 2014-11-26 | 2016-06-02 | Millennium Pharmaceuticals, Inc. | Vedolizumab for the treatment of fistulizing crohn's disease |
| JP6904905B2 (ja) | 2014-12-24 | 2021-07-21 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 抗α４β７インテグリン抗体による治療の結果の予測 |
| MA41636A (fr) | 2015-03-06 | 2018-01-09 | Millennium Pharm Inc | Méthode de traitement de la cholangite sclérosante primitive |
| KR102667332B1 (ko) | 2016-03-14 | 2024-05-20 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 이식편대숙주 질환을 치료하거나 예방하는 방법 |
| JP2019508448A (ja) | 2016-03-14 | 2019-03-28 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 移植片対宿主病予防の方法 |
| MA44483A (fr) | 2016-03-24 | 2019-01-30 | Millennium Pharm Inc | Procédés pour traiter des événements indésirables gastro-intestinaux d'origine immunitaire dans des traitements oncologiques immunitaires |
| WO2017165742A1 (en) | 2016-03-24 | 2017-09-28 | Millennium Pharmaceuticals, Inc. | Methods of treating gastrointestinal immune-related adverse events in anti-ctla4 anti-pd-1 combination treatments |
| US10918716B2 (en) | 2016-05-04 | 2021-02-16 | Millennium Pharmaceuticals, Inc. | Triple combination therapy for treating Crohn's disease |
| US11389533B2 (en) | 2016-06-12 | 2022-07-19 | Takeda Pharmaceutical Company Limited | Method of treating inflammatory bowel disease |
| WO2018104893A1 (en) | 2016-12-06 | 2018-06-14 | Glaxosmithkline Intellectual Property Development Limited | Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life |
| CA3061320A1 (en) | 2017-04-28 | 2018-11-01 | Millennium Pharmaceuticals, Inc. | Method of treating pediatric disorders |
| US20190169291A1 (en) | 2017-07-14 | 2019-06-06 | Pfizer Inc. | Antibodies to MAdCAM |
| JP2022533702A (ja) * | 2019-05-20 | 2022-07-25 | パンディオン・オペレーションズ・インコーポレイテッド | ＭＡｄＣＡＭ標的化免疫寛容 |
| WO2024252368A2 (en) | 2023-06-09 | 2024-12-12 | Takeda Pharmaceutical Company Limited | Methods and compositions for treating ulcerative colitis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5675794A (en) * | 1992-12-15 | 1994-07-04 | Board Of Trustees Of The Leland Stanford Junior University | Mucosal vascular addressin, dna and expression |
-
1996
- 1996-02-12 ES ES96906504T patent/ES2290955T3/es not_active Expired - Lifetime
- 1996-02-12 MX MX9706049A patent/MX9706049A/es active IP Right Grant
- 1996-02-12 WO PCT/US1996/002153 patent/WO1996024673A1/en active IP Right Grant
- 1996-02-12 DE DE69637155T patent/DE69637155T2/de not_active Expired - Lifetime
- 1996-02-12 DK DK96906504T patent/DK0808367T3/da active
- 1996-02-12 JP JP52449196A patent/JP4205162B2/ja not_active Expired - Fee Related
- 1996-02-12 AT AT96906504T patent/ATE366809T1/de active
- 1996-02-12 AU AU49862/96A patent/AU4986296A/en not_active Abandoned
- 1996-02-12 CA CA2212702A patent/CA2212702C/en not_active Expired - Lifetime
- 1996-02-12 NZ NZ303523A patent/NZ303523A/en not_active IP Right Cessation
- 1996-02-12 EP EP96906504A patent/EP0808367B1/en not_active Revoked
- 1996-02-12 PT PT96906504T patent/PT808367E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69637155T2 (de) | 2008-02-07 |
| NZ303523A (en) | 2002-02-01 |
| JP4205162B2 (ja) | 2009-01-07 |
| AU4986296A (en) | 1996-08-27 |
| JPH10513365A (ja) | 1998-12-22 |
| DE69637155D1 (de) | 2007-08-23 |
| CA2212702A1 (en) | 1996-08-15 |
| EP0808367A1 (en) | 1997-11-26 |
| CA2212702C (en) | 2010-04-20 |
| ES2290955T3 (es) | 2008-02-16 |
| ATE366809T1 (de) | 2007-08-15 |
| EP0808367B1 (en) | 2007-07-11 |
| PT808367E (pt) | 2007-10-22 |
| DK0808367T3 (da) | 2007-11-05 |
| WO1996024673A1 (en) | 1996-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9706049A (es) | Adresinas vasculares mucosas y sus usos. | |
| EP1246925B1 (de) | Bi- oder oligomer eines di-, tri-, quattro- oder pentamers von rekombinanten fusionsproteinen | |
| CA2073045C (en) | A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor | |
| JP4001604B2 (ja) | 新規蛋白質及びこれを使用した薬剤の製法 | |
| RU2734169C2 (ru) | Способ получения повышающей регуляции экспрессии PD-L1, полипептиды, конъюгат, слитый полипептид, композиция и комбинация для обеспечения повышающей регуляции экспрессии PD-L1 | |
| US20060173162A1 (en) | Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) | |
| BG112042A (bg) | Човешки антитела, свързващи човешки тумор некрос фактор- ? (tnf-?) | |
| KR970002917B1 (ko) | 인터루킨-i 억제제 | |
| JPH03204896A (ja) | インターフェロンレセプター細胞外断片 | |
| US7338653B2 (en) | Amino-terminally truncated MCP-2 as chemokine antagonists | |
| WO1994025476A1 (en) | Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof | |
| CA2006964A1 (en) | Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full cdna thereof | |
| CA2344590A1 (en) | Treatment of inflammatory disease | |
| KR0150000B1 (ko) | 사람 macif 활성을 지닌 단백질을 암호화하는 유전자, 이 유전자를 함유하는 발현 벡터, 형질전환 세포 및 사람 macif 활성을 갖는 단백질 | |
| EP0698666B1 (en) | Modified epimorphin | |
| AU3439893A (en) | Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy | |
| JPH01503353A (ja) | 免疫グロブリンｅに対するポリペプチド競争体 | |
| JP2000109500A (ja) | ヒト尿由来細胞接着糖蛋白質、その製造方法およびそれを 含有する医薬品 | |
| EP0612349B1 (de) | Neues thrombininhibitorisches protein aus raubwanzen | |
| JP3647473B2 (ja) | 個別性をもつ癌細胞を特徴づけるのに有用な、癌の治療的、予防的、診断的薬剤 | |
| WO1995021916A3 (en) | Pp32: a newly identified cd45-associated protein | |
| Clark-Lewis et al. | Structure-function studies of lymphokines by total chemical synthesis | |
| JP2601199B2 (ja) | ヒトインターロイキン−２蛋白質 | |
| CN118005762A (zh) | 靶向清道夫受体的多肽配体、非共价双靶向分子及其制药用途 | |
| JP3575625B2 (ja) | 新規ペプチド |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights | ||
| FG | Grant or registration |